Shares of 3D Systems plunged more than 7% in extended trading on Wednesday after the 3D printing solution provider reported a wider-than-expected 2Q loss. Lower demand across all products due to COVID-19 pandemic-led shutdowns and reduced level of business activities hurt the company’s overall 2Q results.
DDD) reported a loss per share of $0.13, wider than analysts’ expectations of a loss of $0.10 per share. Revenues fell 28.7% to $112.1 million year-on-year and missed the Street estimate of $117.9 million.” data-reactid=”13″>3D Systems (DDD) reported a loss per share of $0.13, wider than analysts’ expectations of a loss of $0.10 per share. Revenues fell 28.7% to $112.1 million year-on-year and missed the Street estimate of $117.9 million.
Sarkis Sherbetchyan resumed 3D coverage with a Hold rating and price target of $8 (13.3% upside potential). Sherbetchyan is optimistic about the long-term growth prospects of the company as well as the adoption of additive manufacturing in industrial production environments.” data-reactid=”14″>On July 16, B. Riley FBR analyst Sarkis Sherbetchyan resumed 3D coverage with a Hold rating and price target of $8 (13.3% upside potential). Sherbetchyan is optimistic about the long-term growth prospects of the company as well as the adoption of additive manufacturing in industrial production environments.
However, he had cautioned that “Q2 could represent the weakest quarter in fiscal 2020 for industrial activity, and believes both 3D and ExOne should demonstrate improved operating performance in the second half of 2020 relative to Q2.”
price target of $8 implies upside potential of about 13%. (See DDD stock analysis on TipRanks).” data-reactid=”20″>Overall, DDD has a Hold analyst consensus. The average price target of $8 implies upside potential of about 13%. (See DDD stock analysis on TipRanks).
CVS Health Beats 2Q Estimates, Top Analyst Sticks To Hold
Zimmer Biomet Slips 3.7% On 2Q Profit Decline
Fiverr Pops 18% In Pre-Market On Upbeat 2Q Earnings And Raised Outlook” data-reactid=”29″>Related News:
CVS Health Beats 2Q Estimates, Top Analyst Sticks To Hold
Zimmer Biomet Slips 3.7% On 2Q Profit Decline
Fiverr Pops 18% In Pre-Market On Upbeat 2Q Earnings And Raised Outlook
More recent articles from Smarter Analyst:
